MONT-SAINT-HILAIRE, QUEBEC--(Marketwire - January 25, 2008) - Axcan Pharma Inc. ("Axcan" or "the Company")(TSX: AXP)(NASDAQ: AXCA), announced today that the Plan of Arrangement, which involves the acquisition by an affiliate of TPG Capital ("TPG") of all outstanding common shares of Axcan for US$23.35 per share, was approved by 99.87% of the votes cast by holders of Axcan's common shares.
